By expenditures
| Name | Title | Type |
|---|---|---|
| Kendra Leib | DIRECTOR OF FINANCE | Auditee |
| Rebecca L. Jones | SUPERINTENDENT | Auditee |
| Nathan C. Baldermann, Cpa, Cgfm | Principal | Auditee |
| No contacts on file | ||
| ID | Year | Date Accepted | Auditor | Spend |
|---|---|---|---|---|
| 329336 | 2024 | 2024-11-21 | Rehmann Robson LLC | $7.59M |
| 14327 | 2023 | 2024-01-30 | Rehmann Robson LLC | $6.28M |
| 43477 | 2022 | 2022-11-29 | Rehmann Robson LLC | $5.11M |
| Audit | Year | Accepted | Finding | Ref | Severity | Repeat | Requirement |
|---|---|---|---|---|---|---|---|
| 329336 | 2024 | 2024-11-21 | 1086124 | 2024-001 | Material Weakness | Yes | N |
| 329336 | 2024 | 2024-11-21 | 1086123 | 2024-001 | Material Weakness | Yes | N |
| 329336 | 2024 | 2024-11-21 | 1086122 | 2024-001 | Material Weakness | Yes | N |
| 329336 | 2024 | 2024-11-21 | 1086121 | 2024-001 | Material Weakness | Yes | N |
| 329336 | 2024 | 2024-11-21 | 509682 | 2024-001 | Material Weakness | Yes | N |
| 329336 | 2024 | 2024-11-21 | 509681 | 2024-001 | Material Weakness | Yes | N |
| 329336 | 2024 | 2024-11-21 | 509680 | 2024-001 | Material Weakness | Yes | N |
| 329336 | 2024 | 2024-11-21 | 509679 | 2024-001 | Material Weakness | Yes | N |
| 14327 | 2023 | 2024-01-30 | 587103 | 2023-002 | Material Weakness | - | N |
| 14327 | 2023 | 2024-01-30 | 587102 | 2023-002 | Material Weakness | - | N |
| 14327 | 2023 | 2024-01-30 | 587101 | 2023-002 | Material Weakness | - | N |
| 14327 | 2023 | 2024-01-30 | 587100 | 2023-001 | Significant Deficiency | - | B |
| 14327 | 2023 | 2024-01-30 | 587099 | 2023-001 | Significant Deficiency | - | B |
| 14327 | 2023 | 2024-01-30 | 587098 | 2023-001 | Significant Deficiency | - | B |
| 14327 | 2023 | 2024-01-30 | 10661 | 2023-002 | Material Weakness | - | N |
| 14327 | 2023 | 2024-01-30 | 10660 | 2023-002 | Material Weakness | - | N |
| 14327 | 2023 | 2024-01-30 | 10659 | 2023-002 | Material Weakness | - | N |
| 14327 | 2023 | 2024-01-30 | 10658 | 2023-001 | Significant Deficiency | - | B |
| 14327 | 2023 | 2024-01-30 | 10657 | 2023-001 | Significant Deficiency | - | B |
| 14327 | 2023 | 2024-01-30 | 10656 | 2023-001 | Significant Deficiency | - | B |